




Interpretation of Hepatitis B Serologic Test Results
Hepatitis B serologic testing involves measurement of several hepatitis B 
virus (HBV)-specifi c antigens and antibodies. Different serologic “markers” 
or combinations of markers are used to identify different phases of HBV 
infection and to determine whether a patient has acute or chronic HBV 
infection, is immune to HBV as a result of prior infection or vaccination, or 
is susceptible to infection.
Hepatitis B surface 
antigen (HBsAg):  
A protein on the surface 
of hepatitis B virus; it can 
be detected in high levels 
in serum during acute or 
chronic hepatitis B virus 
infection. The presence of 
HBsAg indicates that the 
person is infectious. The 
body normally produces 
antibodies to HBsAg as 
part of the normal immune 
response to infection. 
HBsAg is the antigen used 
to make hepatitis B vaccine.
Hepatitis B surface 
antibody (anti-HBs):  
The presence of anti-HBs 
is generally interpreted as 
indicating recovery and 
immunity from hepatitis B 
virus infection. Anti-HBs 
also develops in a person 
who has been successfully 
vaccinated against 
hepatitis B. 
Total hepatitis B core 
antibody (anti-HBc):  
Appears at the onset 
of symptoms in acute 
hepatitis B and persists 
for life. The presence of 
anti-HBc indicates previous 
or ongoing infection with 
hepatitis B virus in an 
undefi ned time frame. 
IgM antibody to hepatitis B 
core antigen (IgM anti-HBc): 
Positivity indicates recent 
infection with hepatitis B 
virus (<6 mos). Its presence 





HBsAg negative Immune due to natural infection
anti-HBc positive
anti-HBs positive
HBsAg negative Immune due to hepatitis B vaccination
anti-HBc negative
anti-HBs positive








HBsAg negative Interpretation unclear; four possibilities:
anti-HBc positive 1.  Resolved infection (most common)
anti-HBs negative 2.  False-positive anti-HBc, thus susceptible
3.  “Low level” chronic infection
4.  Resolving acute infection
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